gip/glp-1 drugs Dual receptor agonists: New advances for treating type-2 diabetes GLP-1 & GIP Agonists |
Description
In obesity treatment, the hierarchy of outcomes is reversed
That timing change matters for alcohol
Retatrutide simultaneously engages GLP-1, GIP, and glucagon receptors, producing a broader receptor-activation profile
Graphics by Mark LeBay
